Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prevalence of gyrA, gyrB, parC, and parE mutations in clinical isolates of Streptococcus pneumoniae with decreased susceptibilities to different fluoroquinolones and originating from Worldwide Surveillance Studies during the 1997-1998 respiratory season.
Jones ME, Sahm DF, Martin N, Scheuring S, Heisig P, Thornsberry C, Köhrer K, Schmitz FJ. Jones ME, et al. Among authors: heisig p. Antimicrob Agents Chemother. 2000 Feb;44(2):462-6. doi: 10.1128/AAC.44.2.462-466.2000. Antimicrob Agents Chemother. 2000. PMID: 10639387 Free PMC article.
Characterization of fluoroquinolone-resistant mutants of escherichia coli selected in vitro.
Heisig P, Tschorny R. Heisig P, et al. Antimicrob Agents Chemother. 1994 Jun;38(6):1284-91. doi: 10.1128/AAC.38.6.1284. Antimicrob Agents Chemother. 1994. PMID: 8092826 Free PMC article.
In contrast, a clinical isolate of E.coli (isolate 205096) described previously (P. Heisig, H. Schedletzky, and H. Falkenstein-Paul, Antimicrob. ...
In contrast, a clinical isolate of E.coli (isolate 205096) described previously (P. Heisig, H. Schedletzky, and H. Falkenstein …
Comparative activities of clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, ofloxacin, sparfloxacin, and trovafloxacin and nonquinolones linozelid, quinupristin-dalfopristin, gentamicin, and vancomycin against clinical isolates of ciprofloxacin-resistant and -susceptible Staphylococcus aureus strains.
Jones ME, Visser MR, Klootwijk M, Heisig P, Verhoef J, Schmitz FJ. Jones ME, et al. Among authors: heisig p. Antimicrob Agents Chemother. 1999 Feb;43(2):421-3. doi: 10.1128/AAC.43.2.421. Antimicrob Agents Chemother. 1999. PMID: 9925551 Free PMC article.
In vitro activities of fluoroquinolones against the spirochete Borrelia burgdorferi.
Kraiczy P, Weigand J, Wichelhaus TA, Heisig P, Backes H, Schäfer V, Acker G, Brade V, Hunfeld KP. Kraiczy P, et al. Among authors: heisig p. Antimicrob Agents Chemother. 2001 Sep;45(9):2486-94. doi: 10.1128/AAC.45.9.2486-2494.2001. Antimicrob Agents Chemother. 2001. PMID: 11502519 Free PMC article.
70 results